menu
    • menu

    Company profile for Lexicon pharmaceuticals

    NEW Drugs in Dev: 16
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lexicon pharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8800 Technology Forest Place The Woodlands, Texas 77381-1160
    Telephone
    Telephone
    + 281-863-3000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lexpharma.com:443/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lexicon-pharmaceuticals/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/lexpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexicon Presents Sotagliflozin Data in Type 1 Diabetes
    Lexicon Presents Sotagliflozin Data in Type 1 Diabetes

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253719/0/en/Lexicon-to-Present-Data-on-Effect-of-Kidney-Function-on-the-Long-term-Efficacy-and-Safety-of-Sotagliflozin-in-Patients-with-Type-1-Diabetes-at-19th-International-Conference-on-Adva.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Lexicon Pharma Reveals Q4 2025 Financials And Clinical Progress
    Lexicon Pharma Reveals Q4 2025 Financials And Clinical Progress

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3249981/0/en/Lexicon-Pharmaceuticals-Reports-Fourth-Quarter-2025-Financial-Results-and-Provides-Clinical-Updates.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Lexicon Pharma To Join 3 March Investor Conferences
    Lexicon Pharma To Join 3 March Investor Conferences

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248890/0/en/Lexicon-Pharmaceuticals-to-Participate-in-Three-Upcoming-March-Investor-Conferences.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Lexicon Closes $94.6M Public Offering And Private Placement
    Lexicon Closes $94.6M Public Offering And Private Placement

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3234099/0/en/Lexicon-Announces-Closing-of-Approximately-94-6-Million-Public-Offering-and-Concurrent-Private-Placement.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Lexicon Sets $94.6M Public Offering Price With Private Placement
    Lexicon Sets $94.6M Public Offering Price With Private Placement

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229250/0/en/Lexicon-Announces-Pricing-of-Approximately-94-6-Million-Public-Offering-and-Concurrent-Private-Placement.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Lexicon Announces Proposed Public Offering Of Common Stock
    Lexicon Announces Proposed Public Offering Of Common Stock

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3229137/0/en/Lexicon-Announces-Proposed-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search